Skip to main content

RT @uptoTate: Denosumab for erosive hand OA? Abs L05 shows less erosive progression at week 24 with enhancement, includ

Social Author Name
Dr. Rachel Tate
Tweet Content
Denosumab for erosive hand OA? Abs L05 shows less erosive progression at week 24 with enhancement, including pain symptom improvement, at week 48. I can't wait to see more on this! #ACRbest #ACR22 @RheumNow https://t.co/aYb1biVgqt https://t.co/xHXj7nu1IJ

RT @uptoTate: Uric acid appears to be negatively associated with bone mineral density in premenopausal but not in postme

Social Author Name
Dr. Rachel Tate
Tweet Content
Uric acid appears to be negatively associated with bone mineral density in premenopausal but not in postmenopausal women with RA in Abs 1826 #ACR22 @RheumNow https://t.co/Cus73EeMDP https://t.co/e6mrEw4mR4

RT @RHEUMarampa: #lupus pts w/ SKIN involvement had lower HRQoL by SF-36 than those w/o skin involvement as reported by

Social Author Name
sheila
Tweet Content
#lupus pts w/ SKIN involvement had lower HRQoL by SF-36 than those w/o skin involvement as reported by Dr Alician Van from their study. Significance?⬆️ awareness so we can improve coping strategies & support for these pts. #ACR22 @RheumNow ABST#2089 @rheumarhyme @doktora_ging https://t.co/BKKl8BCN9y

RT @AkhilSoodMD: Are we seeing ↑ MDA-5 associated DM post-COVID? Abstr #1857 found since start of pandemic - ↑ in %

Social Author Name
Akhil Sood MD
Tweet Content
Are we seeing ↑ MDA-5 associated DM post-COVID? Abstr #1857 found since start of pandemic - ↑ in % of myositis specific ab testing - ↑ +MDA-5 since onset of pandemic Conclusion: It is possible but we need more data (n = and longitudinal f/u) @RheumNow #ACR22 https://t.co/ZdfDdFc2hZ

RT @DrPetryna: #Abst1669 #ACR22 @RheumNow retrospective study of pts w/checkpoint inhibitor associated arthritis: Rx w/

Social Author Name
Olga Petryna
Tweet Content
#Abst1669 #ACR22 @RheumNow retrospective study of pts w/checkpoint inhibitor associated arthritis: Rx w/ TNFi ± MTX or IL6Ri ± MTX assoctd w/shorter time to cancer progression but faster arthritis control vs pts treated w/MTX alone. optimal approach yet to be identified #ACRBest https://t.co/lyR2C6zR80

RT @doctorRBC: Be wary in the post-Roe v Wade world 1 in 17 pts who tried to fill MTX experienced unexpected barriers Mo

Social Author Name
Robert B Chao, MD
Tweet Content
Be wary in the post-Roe v Wade world 1 in 17 pts who tried to fill MTX experienced unexpected barriers Most issues with pharmacy seeking to confirm purpose of Rx - doctors should include dx on prescription! #ACRBest Abs#L09 @RheumNow #ACR22 https://t.co/WOWCfOPWUk

RT @uptoTate: FMF should be considered in people with short-lived and red mono-oligoarthritis in the large joints of the

Social Author Name
Dr. Rachel Tate
Tweet Content
FMF should be considered in people with short-lived and red mono-oligoarthritis in the large joints of the lower extremities. Abs 1830 #ACR22 @RheumNow https://t.co/86AJkhd0br https://t.co/KuWuTDhgwj

RT @uptoTate: Canakinumab provides a significant reduction in disease severity, attack frequency, and acute phase reacta

Social Author Name
Dr. Rachel Tate
Tweet Content
Canakinumab provides a significant reduction in disease severity, attack frequency, and acute phase reactant levels in FMF. Abs 1834 #ACR22 @RheumNow https://t.co/3JYDi7eaBU https://t.co/NepMkQniiB

RT @uptoTate: ORAL Surveillance update! Composite ischemic CV/HF risk not numerically different w/ tofa vs TNFi. In pts

Social Author Name
Dr. Rachel Tate
Tweet Content
ORAL Surveillance update! Composite ischemic CV/HF risk not numerically different w/ tofa vs TNFi. In pts w/ ASCVD hx, MACE endpoints were numerically higher w/ tofa. CV risk was higher w/ tofa 10 mg BID vs TNFi. Check out CIs! Abs L06 #ACR22 @RheumNow https://t.co/XXTsU4el66 https://t.co/WvFqziKVkT

RT @AkhilSoodMD: Is there ↑ delay in #Dermatomyositis dx and tx by race? Abstr #1861 showed: Median # of days from Dx

Social Author Name
Akhil Sood MD
Tweet Content
Is there ↑ delay in #Dermatomyositis dx and tx by race? Abstr #1861 showed: Median # of days from Dx → Tx by race: - White: 4 days - Hispanic: 14 days - Black: 21 Whites vs other races: 4 vs 14 days @RheumNow #ACR22 https://t.co/wWgfgtRHa5
Subscribe to
×